HADWEN HEALTH
GLEVUM WAY, ABBEYDALE, GLOUCESTERCKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 220 | 266 | 82.7% | |
CKD 4 | 2008 | 317 | 351 | 90.3% | |
CKD 5 | 2009 | 52 | 53 | 98.1% | |
CKD 5 | 2010 | 38 | 38 | 100.0% | |
CKD 5 | 2011 | 38 | 40 | 95.0% | |
CKD 5 | 2012 | 34 | 37 | 91.9% | |
CKD 5 | 2013 | 31 | 34 | 91.2% | |
CKD003 | 2014 | 32 | 33 | 97.0% | |
CKD003 | 2015 | 33 | 34 | 97.1% | |
NM84 | 2016 | 38 | 49 | 77.6% | |
NM84 | 2017 | 48 | 60 | 80.0% | |
NM84 | 2018 | 56 | 68 | 82.4% | |
NM84 | 2020 | 57 | 78 | 73.1% | |
NM84 | 2022 | 53 | 87 | 60.9% |